Overview of the 340B Drug Pricing Program

Commission members
Glenn M. Hackbarth, J.D., chairman
Bend, OR
Jon B. Christianson, Ph.D., vice chairman
School of Public Health at the University of Minnesota
Minneapolis, MN
Term expires April 2015
Alice Coombs, M.D.
Milton Hospital and South Shore
Hospital
Weymouth, MA
Glenn M. Hackbarth, J.D.
Jack Hoadley, Ph.D.
Health Policy Institute, Georgetown
University
Washington, DC
David Nerenz, Ph.D.
Henry Ford Health System
Detroit, MI
Rita Redberg, M.D., M.Sc.
University of California at San
Francisco Medical Center
San Francisco, CA
Craig Samitt, M.D., M.B.A.
Oliver Wyman
Paradise Valley, AZ
Term expires April 2016
Scott Armstrong, M.B.A.,
F.A.C.H.E.
Group Health Cooperative
Seattle, WA
Katherine Baicker, Ph.D.
Harvard School of Public Health
Boston, MA
Jon B. Christianson, Ph.D.
Herb B. Kuhn
Missouri Hospital Association
Jefferson City, MO
Mary Naylor, Ph.D.,
F.A.A.N., R.N.
University of Pennsylvania, School of
Nursing
Philadelphia, PA
Cori Uccello, F.S.A.,
M.A.A.A., M.P.P.
American Academy of Actuaries
Washington, DC
Term expires April 2017
Kathy Buto, M.P.A.
Arlington, VA
Francis “Jay” Crosson, M.D.
Palo Alto, CA
Bill Gradison Jr., M.B.A.,
D.C.S.
McLean, VA
William J. Hall, M.D.,
M.A.C.P.
University of Rochester School of
Medicine
Rochester, NY
Warner Thomas, M.B.A.
Ochsner Health System
New Orleans, LA
Overview of the 340B Drug Pricing Program | May 2015 33